Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Beverly Moy

Showing results (71-80 of 168) with videos related to

Pageof 17
Sort By:
Psycho-Oncology|January 25, 2007
Long-term psychosocial adjustment of older vs younger survivors of breast and endometrial cancerAlice B Kornblith, Mark Powell, Meredith M Regan, et al.
JAMA Oncology|March 30, 2018
Patterns in Health Care Access and Affordability Among Cancer Survivors During Implementation of the Affordable Care ActRyan D Nipp, Amy M Shui, Giselle K Perez, et al.
Therapeutic Advances in Medical Oncology|January 16, 2023
Adjuvant trastuzumab and vinorelbine for early-stage HER2+ breast cancerShannon McLaughlin, Erika Nakajima, Yael Bar, et al.
The Oncologist|March 16, 2016
Financial Burden of Cancer Clinical Trial Participation and the Impact of a Cancer Care Equity ProgramRyan D Nipp, Hang Lee, Elizabeth Powell, et al.
BMC Cancer|April 25, 2020
Different associations of tumor PIK3CA mutations and clinical outcomes according to aspirin use among women with metastatic hormone receptor positive breast cancerAnne Marie McCarthy, Nitya Pradeep Kumar, Wei He, et al.
The New England Journal of Medicine|July 2, 2020
Case 22-2020: A 62-Year-Old Woman with Early Breast Cancer during the Covid-19 PandemicLaura M Spring, Michelle C Specht, Rachel B Jimenez, et al.
Breast Cancer Research and Treatment|November 21, 2025
Improving adjuvant endocrine therapy initiation among patients with breast cancer: a nurse-led, culturally sensitive pilot studyKathryn E Post, Laura Dunderdale, Shibani Datta, et al.
Clinical Breast Cancer|August 19, 2020
Implementation of a Brief Screening Tool to Identify Needs of Breast Cancer SurvivorsAllison L McDonough, Yvonne Lei, Agnes H Kwak, et al.
Breast Cancer Research and Treatment|July 27, 2020
A system for risk stratification and prioritization of breast cancer surgeries delayed by the COVID-19 pandemic: preparing for re-entryBarbara L Smith, Anvy Nguyen, Jenna E Korotkin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 19, 2010
Dose-dense doxorubicin and cyclophosphamide followed by weekly paclitaxel with trastuzumab and lapatinib in HER2/neu-overexpressed/amplified breast cancer is not feasible because of excessive diarrheaChau Dang, Nancy Lin, Beverly Moy, et al.
Pageof 17

Showing results (71-80 of 168) with videos related to

Sort By:
Pageof 17
Psycho-Oncology|January 25, 2007
Long-term psychosocial adjustment of older vs younger survivors of breast and endometrial cancerAlice B Kornblith, Mark Powell, Meredith M Regan, et al.
JAMA Oncology|March 30, 2018
Patterns in Health Care Access and Affordability Among Cancer Survivors During Implementation of the Affordable Care ActRyan D Nipp, Amy M Shui, Giselle K Perez, et al.
Therapeutic Advances in Medical Oncology|January 16, 2023
Adjuvant trastuzumab and vinorelbine for early-stage HER2+ breast cancerShannon McLaughlin, Erika Nakajima, Yael Bar, et al.
The Oncologist|March 16, 2016
Financial Burden of Cancer Clinical Trial Participation and the Impact of a Cancer Care Equity ProgramRyan D Nipp, Hang Lee, Elizabeth Powell, et al.
BMC Cancer|April 25, 2020
Different associations of tumor PIK3CA mutations and clinical outcomes according to aspirin use among women with metastatic hormone receptor positive breast cancerAnne Marie McCarthy, Nitya Pradeep Kumar, Wei He, et al.
The New England Journal of Medicine|July 2, 2020
Case 22-2020: A 62-Year-Old Woman with Early Breast Cancer during the Covid-19 PandemicLaura M Spring, Michelle C Specht, Rachel B Jimenez, et al.
Breast Cancer Research and Treatment|November 21, 2025
Improving adjuvant endocrine therapy initiation among patients with breast cancer: a nurse-led, culturally sensitive pilot studyKathryn E Post, Laura Dunderdale, Shibani Datta, et al.
Clinical Breast Cancer|August 19, 2020
Implementation of a Brief Screening Tool to Identify Needs of Breast Cancer SurvivorsAllison L McDonough, Yvonne Lei, Agnes H Kwak, et al.
Breast Cancer Research and Treatment|July 27, 2020
A system for risk stratification and prioritization of breast cancer surgeries delayed by the COVID-19 pandemic: preparing for re-entryBarbara L Smith, Anvy Nguyen, Jenna E Korotkin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 19, 2010
Dose-dense doxorubicin and cyclophosphamide followed by weekly paclitaxel with trastuzumab and lapatinib in HER2/neu-overexpressed/amplified breast cancer is not feasible because of excessive diarrheaChau Dang, Nancy Lin, Beverly Moy, et al.
Pageof 17